TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
PharmInfo i Uppsala AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
200
|
460
|
729 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
154
|
249
|
384 |
| EBITDA |
187
|
282
|
477 |
| Total assets |
2,783
|
3,004
|
3,022 |
| Current assets |
2,456
|
2,982
|
2,951 |
| Current liabilities |
95
|
197
|
211 |
| Equity capital |
2,534
|
2,613
|
2,606 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
91.1%
|
87.0%
|
86.2% |
| Turnover per employee |
200
|
460
|
729 |
| Profit as a percentage of turnover |
77.0%
|
54.1%
|
52.7% |
| Return on assets (ROA) |
5.5%
|
8.3%
|
12.7% |
| Current ratio |
2585.3%
|
1513.7%
|
1398.6% |
| Return on equity (ROE) |
6.1%
|
9.5%
|
14.7% |
| Change turnover |
-260
|
-269
|
729 |
| Change turnover % |
-57%
|
-37% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.